Results 111 to 120 of about 1,414 (186)

COMPARE COMBINED USE OF ANTI-VEGF DRUGS DURING OR AFTER PARS PLANA VITRECTOMY FOR DIABETIC MACULAR EDEMA GUIDED BY MICROSCOPE-INTEGRATED OPTICAL COHERENCE TOMOGRAPHY. [PDF]

Retina
Zhu J, Liu J, Chen YX, Yang XW, Zhu RR.
europepmc   +1 more source

Clinical efficacy of Conbercept combined with pars plana vitrectomy for proliferative diabetic retinopathy. [PDF]

Am J Transl Res
Chen Y, Wang M, Gao J.
europepmc   +1 more source

Macular Telangiectasia type 1 treated with integrated traditional Chinese acupuncture and Conbercept: a case report. [PDF]

Front Med (Lausanne)
Liu Z, Liu C, Yang S, Tang X, Wang J, Zhang J.   +5 more
europepmc   +1 more source

Cost-effectiveness analysis of the use of faricimab in diabetic macular edema in China. [PDF]

J Comp Eff Res
Shi F, Tan S, Shu Y, Liu T, Xia Y, Buehrer C, Han S.   +6 more
europepmc   +1 more source

Tetrahedral DNA nano-PROTACs enable enhanced ocular penetration and efficient nucleolin degradation for choroidal neovascularization therapy. [PDF]

Signal Transduct Target Ther
Song J, Wei X, He K, Ge R, Li M, Bai T, Han H, You C, Liao M, Pan W, Chen M, Belfort R, Fernandes RAB, Xie S, Yan H.   +14 more
europepmc   +1 more source

Case report: Two cases of juxtapapillary retinal capillary hemangioma treated with intraocular cryotherapy. [PDF]

Front Med (Lausanne)
Zhang W, Yang Y, Ren C, Jiang X, Lu F.
europepmc   +1 more source

Comparison of Clinical Efficacy of Intravitreal Injection of Conbercept Combined with Triamcinolone Acetonide and Conbercept Alone on the Treatment of CRVO in Young Adults

Advances in Clinical Medicine, 2020
openaire   +1 more source

Mannose-modified miR-223 nanoparticles remodel pathological microenvironment to suppress inflammation and angiogenesis for neovascular AMD therapy. [PDF]

Int J Pharm X
Wang Y, Zhang W, Cheng F, Wang J, Xiao K, Wang D, Zhao X, Zou R, Yao Q.   +8 more
europepmc   +1 more source

Association between systemic blood pressure control and outcomes of Conbercept treatment for macular edema secondary to retinal vein occlusion. [PDF]

Front Med (Lausanne)
Wu Q, Gong B, Zhang H, Tao Y, Zhang C, Li G, Yang N.   +6 more
europepmc   +1 more source

Posterior reversible encephalopathy syndrome across 22 VEGF-pathway inhibitors in the FDA adverse event reporting system: reporting patterns and reporting-interval characteristics. [PDF]

Front Pharmacol
Li J, Cheng Y, Yang Y.
europepmc   +1 more source